Literature DB >> 12576233

Interferon-gamma-inducible subunits are incorporated in human brain 20S proteasome.

Marco Piccinini1, Michael Mostert, Sabrina Croce, Simone Baldovino, Mauro Papotti, Maria Teresa Rinaudo.   

Abstract

In most tissues expressing MHC class I molecules, proteasomes incorporating IFN-gamma-inducible subunits, defined immuno-proteasomes, exist together with constitutive proteasomes. In physiological conditions, the central nervous system expresses neither MHC class I molecules nor TAP1 and TAP2 transporters but besides being constitutive, it is unknown whether immuno-proteasomes are also present in this tissue. We present evidence that in human brain, the two types of proteasome exist suggesting that under physiological conditions, the mechanisms regulating expression of IFN-gamma-inducible subunits as well as of MHC class I molecules and TAP1 and TAP2 transporters in nervous tissue, are not entirely coordinated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576233     DOI: 10.1016/s0165-5728(02)00439-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  14 in total

Review 1.  Chemical genetics: exploring the role of the proteasome in cell biology using natural products and other small molecule proteasome inhibitors.

Authors:  Kyung Bo Kim; Craig M Crews
Journal:  J Med Chem       Date:  2008-04-05       Impact factor: 7.446

Review 2.  Emerging roles of immunoproteasomes beyond MHC class I antigen processing.

Authors:  Frédéric Ebstein; Peter-Michael Kloetzel; Elke Krüger; Ulrike Seifert
Journal:  Cell Mol Life Sci       Date:  2012-03-02       Impact factor: 9.261

3.  Proteasome Levels and Activity in Pregnancies Complicated by Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Thrombocytopenia (HELLP) Syndrome.

Authors:  Kathryn Berryman; Catalin S Buhimschi; Guomao Zhao; Michelle Axe; Megan Locke; Irina A Buhimschi
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

4.  LMP2-specific inhibitors: chemical genetic tools for proteasome biology.

Authors:  Yik Khuan Ho; Paola Bargagna-Mohan; Marie Wehenkel; Royce Mohan; Kyung-Bo Kim
Journal:  Chem Biol       Date:  2007-04

Review 5.  The proteasome and the degradation of oxidized proteins: Part I-structure of proteasomes.

Authors:  Tobias Jung; Tilman Grune
Journal:  Redox Biol       Date:  2013-01-19       Impact factor: 11.799

6.  Aspects of innate immunity and Parkinson's disease.

Authors:  Yue Huang; Glenda M Halliday
Journal:  Front Pharmacol       Date:  2012-03-08       Impact factor: 5.810

7.  Amniotic Fluid Proteasome and Immunoproteasome in the Setting of Intra-Amniotic Infection, Inflammation, and Preterm Birth.

Authors:  Courtney A Ware; Catalin S Buhimschi; Guomao Zhao; Yara El Helou; Irina A Buhimschi
Journal:  Reprod Sci       Date:  2021-03-04       Impact factor: 2.924

8.  Poly-Ub-substrate-degradative activity of 26S proteasome is not impaired in the aging rat brain.

Authors:  Carolin Giannini; Alexander Kloß; Sabrina Gohlke; Michele Mishto; Thomas P Nicholson; Paul W Sheppard; Peter-Michael Kloetzel; Burkhardt Dahlmann
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

9.  PSMB9 codon 60 polymorphisms have no impact on the activity of the immunoproteasome catalytic subunit B1i expressed in multiple types of solid cancer.

Authors:  Ji Eun Park; Lin Ao; Zachary Miller; Kyungbo Kim; Ying Wu; Eun Ryoung Jang; Eun Young Lee; Kyung Bo Kim; Wooin Lee
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

10.  Circulating proteasome activity following mild head injury in children.

Authors:  Marzena Tylicka; Ewa Matuszczak; Wojciech Dębek; Adam Hermanowicz; Halina Ostrowska
Journal:  Childs Nerv Syst       Date:  2014-04-04       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.